{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:07:06Z","timestamp":1788865626072,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1124\/mol.118.113001","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T18:14:54Z","timestamp":1535566494000},"page":"1246-1255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells"],"prefix":"10.1016","volume":"94","author":[{"given":"Sean T.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungsun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ku-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.118.113001_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.onc.1208296","article-title":"The AKT\/I kappa B kinase pathway promotes angiogenic\/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin","volume":"24","author":"Agarwal","year":"2005","journal-title":"Oncogene"},{"key":"10.1124\/mol.118.113001_bib2","first-page":"770","article-title":"Safety evaluation of ritanserin--an investigational serotonin antagonist","volume":"20","author":"Barone","year":"1986","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1124\/mol.118.113001_bib3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/carcin\/bgh075","article-title":"RasGTPase-activating protein is a target of caspases in spontaneous apoptosis of lung carcinoma cells and in response to etoposide","volume":"25","author":"Bartling","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1124\/mol.118.113001_bib4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol Cell"},{"key":"10.1124\/mol.118.113001_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bcp.2016.10.011","article-title":"Dual activities of ritanserin and R59022 as DGK\u03b1 inhibitors and serotonin receptor antagonists","volume":"123","author":"Boroda","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.118.113001_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccr.2013.09.012","article-title":"Requirement for interaction of PI3-kinase p110\u03b1 with RAS in lung tumor maintenance","volume":"24","author":"Castellano","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1124\/mol.118.113001_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/cb500893q","article-title":"Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival","volume":"10","author":"Chang","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1124\/mol.118.113001_bib8","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1038\/onc.2016.166","article-title":"eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis","volume":"35","author":"Cheng","year":"2016","journal-title":"Oncogene"},{"key":"10.1124\/mol.118.113001_bib9","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1124\/mol.118.113001_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1158\/2159-8290.CD-12-0215","article-title":"Diacylglycerol kinase \u03b1 is a critical signaling node and novel therapeutic target in glioblastoma and other cancers","volume":"3","author":"Dominguez","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1124\/mol.118.113001_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2105-5-113","article-title":"MUSCLE: a multiple sequence alignment method with reduced time and space complexity","volume":"5","author":"Edgar","year":"2004","journal-title":"BMC Bioinformatics"},{"key":"10.1124\/mol.118.113001_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chembiol.2017.06.007","article-title":"The ligand binding landscape of diacylglycerol kinases","volume":"24","author":"Franks","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1124\/mol.118.113001_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/gcc.2870030407","article-title":"Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small-cell lung cancer","volume":"3","author":"Graziano","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1124\/mol.118.113001_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrm783","article-title":"Closing in on the biological functions of Fps\/Fes and Fer","volume":"3","author":"Greer","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/mol.118.113001_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc2110","article-title":"Protein kinase C and other diacylglycerol effectors in cancer","volume":"7","author":"Griner","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.118.113001_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature08833","article-title":"RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","volume":"464","author":"Hatzivassiliou","year":"2010","journal-title":"Nature"},{"key":"10.1124\/mol.118.113001_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","article-title":"Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF","volume":"140","author":"Heidorn","year":"2010","journal-title":"Cell"},{"key":"10.1124\/mol.118.113001_bib18","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1021\/jm400898x","article-title":"Development and optimization of piperidyl-1,2,3-triazole ureas as selective chemical probes of endocannabinoid biosynthesis","volume":"56","author":"Hsu","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/mol.118.113001_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrd3373","article-title":"Cell death assays for drug discovery","volume":"10","author":"Kepp","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.118.113001_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1541-7786.MCR-16-0161","article-title":"Amplification of TLK2 induces genomic instability via impairing the G2-M checkpoint","volume":"14","author":"Kim","year":"2016","journal-title":"Mol Cancer Res"},{"key":"10.1124\/mol.118.113001_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc2787","article-title":"Targeting the cancer kinome through polypharmacology","volume":"10","author":"Knight","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.118.113001_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","article-title":"Signal transduction through MAP kinase cascades","volume":"74","author":"Lewis","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.1124\/mol.118.113001_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/acs.biochem.7b00962","article-title":"Deconstructing lipid kinase inhibitors by chemical proteomics","volume":"57","author":"McCloud","year":"2018","journal-title":"Biochemistry"},{"key":"10.1124\/mol.118.113001_bib24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/1541-7786.MCR-13-0604","article-title":"The lipid kinase PI4KIII\u03b2 is highly expressed in breast tumors and activates Akt in cooperation with Rab11a","volume":"12","author":"Morrow","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1124\/mol.118.113001_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bmcl.2012.11.061","article-title":"Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2)","volume":"23","author":"Nagano","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.118.113001_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/neuonc\/nox119","article-title":"Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha","volume":"20","author":"Olmez","year":"2018","journal-title":"Neuro-oncol"},{"key":"10.1124\/mol.118.113001_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chembiol.2011.04.011","article-title":"In situ kinase profiling reveals functionally relevant properties of native kinases","volume":"18","author":"Patricelli","year":"2011","journal-title":"Chem Biol"},{"key":"10.1124\/mol.118.113001_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bi062142x","article-title":"Functional interrogation of the kinome using nucleotide acyl phosphates","volume":"46","author":"Patricelli","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/mol.118.113001_bib29","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1124\/mol.118.113001_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cell.2018.01.001","article-title":"5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology","volume":"172","author":"Peng","year":"2018","journal-title":"Cell"},{"key":"10.1124\/mol.118.113001_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"key":"10.1124\/mol.118.113001_bib32","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1158\/1078-0432.CCR-15-0413","article-title":"Molecular pathways: targeting diacylglycerol kinase alpha in cancer","volume":"21","author":"Purow","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.118.113001_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS: the European Molecular Biology Open Software Suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet"},{"key":"10.1124\/mol.118.113001_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbalip.2007.04.006","article-title":"Diacylglycerol kinases: why so many of them?","volume":"1771","author":"Sakane","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.118.113001_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ccell.2017.12.014","article-title":"c-RAF ablation induces regression of advanced Kras\/Trp53 mutant lung adenocarcinomas by a mechanism independent of MAPK signaling","volume":"33","author":"Sanclemente","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1124\/mol.118.113001_bib36","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1096\/fasebj.9.9.7601337","article-title":"The MAPK signaling cascade","volume":"9","author":"Seger","year":"1995","journal-title":"FASEB J"},{"key":"10.1124\/mol.118.113001_bib37","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1039\/C8SC00043C","article-title":"Isoform-selective activity-based profiling of ERK signaling","volume":"9","author":"Shin","year":"2018","journal-title":"Chem Sci (Camb)"},{"key":"10.1124\/mol.118.113001_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"key":"10.1124\/mol.118.113001_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2407-9-174","article-title":"Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro study","volume":"9","author":"Wang","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1124\/mol.118.113001_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2015.04.005","article-title":"FDA-approved small-molecule kinase inhibitors","volume":"36","author":"Wu","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.118.113001_bib41","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/emboj.2010.81","article-title":"The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation","volume":"29","author":"Ye","year":"2010","journal-title":"EMBO J"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24008186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.118.113001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:26:17Z","timestamp":1739960777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24008186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0026895X24008186"],"URL":"https:\/\/doi.org\/10.1124\/mol.118.113001","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.118.113001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}